Overview

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy and safety of AzA 15% Gel in the treatment of mild to moderate perioral dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid